Bezplatná linka pomoc AIDS odkudkoliv tel.: 800 1 44444
Gomes CM, Giraldo PC, Gomes Fde A, Amaral R, Passos MR, Gonçalves AK.
Genital ulcers in women: clinical, microbiologic and histopathologic characteristics.
Braz J Infect Dis. 2007 Apr;11(2):254-60.
PMID: 17625773 [PubMed - indexed for MEDLINE
Marrazzo J.
Syphilis and other sexually transmitted diseases in HIV infection.
Top HIV Med. 2007 Feb-Mar;15(1):11-6.
PMID: 17406079 [PubMed - indexed for MEDLINE
Jebbari H, Alexander S, Ward H, Evans B, Solomou M, Thornton A, Dean G, White J, French P, Ison C; UK LGV Incident Group.
Sex Transm Infect.
2007 Jul;83(4):324-6. Epub 2007 Jun 25.
Fine DM, Atta MG.
Kidney disease in the HIV-infected patient.
AIDS Patient Care STDS. 2007 Nov;21(11):813-24.Review.
PMID: 18240891 [PubMed - indexed for MEDLINE
Holden BM, Brook MG. Saudi J Kidney Dis Transpl.
Chronic Renal Disease Associated with HIV Infection.
2002 Jul-Sep;13(3):344-52.
Letendre S, Ances B, Gibson S, Ellis RJ.
Neurologic complications of HIV disease and their treatment.
Top HIV Med. 2007 Apr-May;15(2):32-9.
PMID: 17485785 [PubMed - indexed for MEDLINE
Benhamou Y.
Treatment algorithm for chronic hepatitis B in HIV-infected patients.
J Hepatol. 2006;44(1 Suppl):S90-4. Epub 2005 Nov 28. Review.
PMID: 16352368 [PubMed - indexed for MEDLINE]
Keiser PH, Sension MG, DeJesus E, Rodriguez A, Olliffe JF, Williams VC, Wakeford JH, Snidow JW, Shachoy-Clark AD, Fleming JW, Pakes GE, Hernandez JE; ESS40003 Study Team. BMC Infect Dis.
Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment.
2005 Jan 12;5(1):2.
Sadosky A, McDermott AM, Brandenburg NA, Strauss M
A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions. Pain Pract.
2008 Mar;8(1):45-56.
Tyto stránky obsahují texty ve formátu .pdf. K jejich prohlížení musíte mít nainstalovaný Acrobat Reader od společnosti Adobe, který je zdarma ke stažení zde.
S hlášením nežádoucích účinků nebo neúčinnosti vakcíny se obracejte prostřednictvím vašeho lékaře na firmu GSK email: cz.safety@gsk.com , telefon: 222001111.